Search Within

Alison Moskowitz

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (123)
  2. Journal Article (83)
  3. Research Letter (7)
  4. Review (5)
  5. Correspondence (1)
  6. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (220)
  2. Department of Medicine (220)
  3. Hematologic Malignancies, Division of (220)
  4. Lymphoma (220)
  5. Population Sciences Research Program (220)
  6. Survivorship Research (114)

More Groups

People
  1. Steven Horwitz (220)
  2. Andrew Zelenetz (102)
  3. Ariela Noy (99)
  4. Paul Hamlin (95)
  5. Maria Palomba (90)
  6. David Straus (89)

More People

Years
  1. 2025 (5)
  2. 2024 (14)
  3. 2023 (21)
  4. 2022 (13)
  5. 2021 (24)
  6. 2020 (24)

More Years

Publications
  1. Blood (92)
  2. Hematological Oncology (15)
  3. Journal of Clinical Oncology (15)
  4. Journal of the American Academy of Dermatology (12)
  5. Blood Advances (10)
  6. Blood Cancer Journal (8)

More Publications

Publishers
  1. American Society of Hematology (102)
  2. Wiley Blackwell (21)
  3. American Society of Clinical Oncology (15)
  4. Elsevier Inc. (12)
  5. Mosby Elsevier (12)
  6. Nature Publishing Group (11)

More Publishers

Results (220)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Meeting Abstract

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; Horwitz, S. M.; Geller, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Infectious complications in patients with relapsed or refractory (R/R) Non-Hodgkin's lymphoma (NHL) treated with the anti-CD20xCD3 bispecific antibody (BsAb) mosunetuzumab
    Meeting Abstract

    Shahid, Z.; Okwali, M.; Joseph, A.; Seo, S. K.; Lue, J. K.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cumulative incidence of myeloid neoplasms in patients with nodal T-follicular helper cell lymphoma
    Meeting Abstract

    Stuver, R.; Ganesan, N.; Dogan, A.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Lewis, N.; Moskowitz, A.; Shah, G. L.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Quality of life and global response score in cutaneous T-cell lymphoma
    Meeting Abstract

    Khan, N.; Drill, E.; Moskowitz, A.; Shinohara, M. M.; Larocca, C.; Querfeld, C.; Zain, J. M.; Horwitz, S. M.
    Blood (2023)

    Fulltext@MSK | Save
  • Polytypic B-cells, B-cell lymphoproliferative disorders/lymphomas, and neoplastic T-cells divergently differentiate from TET2-/ DNMT3A-mutated clonal hematopoiesis in patients with follicular helper T-cell lymphomas/lymphoproliferative disorders
    Meeting Abstract

    Lewis, N.; Petrova-Drus, K.; Sardana, R.; Gao, Q.; Sethi, S.; Xiao, W.; Roshal, M.; Baik, J.; Bhurtel, H.; Moskowitz, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save